Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 101 PS2-13-10 | DOI: 10.1530/endoabs.101.PS2-13-10

ETA2024 Poster Presentations Medullary thyroid cancer-2 (10 abstracts)

Pathological and molecular characterization of peritumoral desmoplasia in medullary thyroid carcinoma

Andrea Contarino 1 , Gianluca Lopez 2 , Chiara Bughetti 3 , Elisabetta Iofrida 4 , Alessia Dolci 5 & Giovanna Mantovani 6


1University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy; 2Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy, Division of Pathology, Fondazione Irccs Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Italy; 3School of Pathology, University of Milan, Milan, Italy, Division of Pathology, Fondazione Irccs Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Italy; 4Fondazione Irccs Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Otolaryngology and Head and Neck Surgery Unit, Italy; 5Endocrinology, Fondazione Irccs Cà Granda, Ospedale Maggiore Policlinico, Endocrinology Unit, Fondazione Irccs Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Italy; 6University of Milan, Fondazione Irccs Ca’ Granda, Clinical Sciences and Community Health, Milano, Italy


Background: Medullary thyroid carcinoma (MTC) has a high predisposition to neck lymph node involvement, which correlates with worse outcome. Peritumoral stromal desmoplasia, defined as the presence of a newly formed stroma surrounding tumor cells, is a strong predictor of lymph node metastases in MTC.

Objective: The main purpose of the present study is to characterize peritumoral stromal desmoplasia in MTC, through the identification of other associated histopathological features and their possible molecular basis.

Methods: We performed a retrospective observational study on patients with histologically proven MTC diagnosed at our Institution from 2010 to 2024. Paraffin-embedded thyroid tumor tissue was collected for each patient for histopathological analysis. The selected patients’ medical records were revised up until the last follow-up visit in order to assess their disease status at the end of the study.

Results: The study population included 51 patients (32 female, 19 male), of which 44 with sporadic MTC. Desmoplasia was observed in 49% of patients (Table), who did not differ in age, sex and duration of follow-up compared to cases without desmoplasia. Desmoplasia was significantly associated with higher basal calcitonin and procalcitonin levels (P = 0.001 and 0.019, respectively), primary tumor size (P=0.007), lymph node metastases (P = 0.014) and angioinvasion (P = 0.007). There was no significant association with grade of intratumoral fibrosis (12.5% vs 8%), necrosis (12% vs 7.7%) and tumor capsule invasion (88.9% vs 61.5%), although these features were more represented in MTCs with desmoplasia. In cases with available molecular analysis (n = 20), somatic RET mutations were identified both in MTCs with and without desmoplasia (57.1% vs 66.7%), and there were no differences in the distribution of the type of mutation detected (M918T, C634 or others). At the end of follow-up (median 40.8 months), desmoplasia was significantly associated with a higher prevalence of disease persistence (P = 0.05).

Desmoplasia n = 25 (49)Non desmoplasia n = 26 (51)p
RET somatic mutation, n8/14 6/9ns
Calcitonin (pg/ml), median [IQR]466,5 [118-2861,3]73,8 [20,9-1132]0,001
CEA (ng/ml), median [IQR]21,5 [7,1-44,8]5,6 [4,4-76]ns
Procalcitonin (ng/ml), median [IQR]3,6 [0,8-33,7]0,4 [0,1-5,5]0,019
Primary tumor size (mm), median [IQR] 12 [8-21]8 [6-10,3]0,007
Angioinvasion, n (%)10 (40)2 (7,7)0,007
Lymph node involvement, n (%)9 (36)2 (7,7)0,014
Persistence at last follow up, n (%) 11 (44)5 (19,2)0,05
Follow-up period (months), median [IQR] 35,9 [11,2-52,8]24,1 [10,8-40,8]ns

Conclusions: Desmoplasia in MTC is associated not only with lymph node metastases but also with angioinvasion and increased tumor size, regardless of the presence and type of RET mutation. Further studies on larger series may clarify whether desmoplasia is associated with other pathological factors with a negative prognosis.

Volume 101

46th Annual Meeting of the European Thyroid Association (ETA) 2024

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.